{"id":1623,"date":"2022-06-01T17:59:02","date_gmt":"2022-06-01T17:59:02","guid":{"rendered":"https:\/\/lab.research.sickkids.ca\/hayeems\/?page_id=1623"},"modified":"2024-07-08T15:28:44","modified_gmt":"2024-07-08T15:28:44","slug":"c-guide","status":"publish","type":"page","link":"https:\/\/lab.research.sickkids.ca\/hayeems\/c-guide\/","title":{"rendered":"Provider Outcomes: C-GUIDE\u2122"},"content":{"rendered":"

Clinician-reported Genetic testing Utility <\/span>InDEx<\/span> (C-GUIDE)\u2122<\/span><\/span><\/h2><\/div>
<\/div><\/div><\/div><\/div>

About C-GUIDE\u2122<\/h2><\/div>
<\/div>
\n

Decision makers require evidence of clinical utility to inform policy and funding decisions related to genetic testing. To address this, we have developed and validated a novel outcome measure to assess the clinical utility of genetic testing from providers\u2019 perspectives.\u202f<\/span>\u202f<\/span>\u00a0<\/span><\/p>\n

\u202f<\/span>C-GUIDE\u2122 is designed to capture the clinical utility of a genetic test as it relates to:<\/span>\u00a0<\/span><\/p>\n